Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Clinical characterization and therapeutic outcomes of patients (pts) with colorectal cancer (CRC) harboring somatic BRCA1/2 mutations.
Authors
Deepak Bhamidipati
The University of Texas MD Anderson Cancer Center, Houston, TX
Deepak Bhamidipati , Jaime Haro-Silerio , Ecaterina Elena Dumbrava , Siqing Fu , David S. Hong , Daniel D. Karp , Aung Naing , Shubham Pant , Sarina A. Piha-Paul , Jordi Rodon Ahnert , Apostolia Maria Tsimberidou , Amber Johnson , Michael Sangmin Lee , Arvind Dasari , Kanwal Pratap Singh Raghav , Van K. Morris II, Michael J. Overman , Scott Kopetz , Funda Meric-Bernstam , Timothy A. Yap
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 134)
DOI
10.1200/JCO.2024.42.3_suppl.134
Abstract #
134
Poster Bd #
H19
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Characteristics of colorectal cancer (CRC) patients with BRCA1 and BRCA2 mutations.
First Author: Madiha Naseem
Poster
2022 ASCO Genitourinary Cancers Symposium
DNA damaging therapies in patients (pts) with prostate cancer (PC) and pathogenic alterations in homologous recombination repair (HRR) genes.
First Author: Laura Graham
Poster
2019 ASCO Annual Meeting
Association of secondary somatic mutations in BRCA1/2 with clinical resistance to PARP inhibitors and chemotherapy.
First Author: Lingjun Zhu
First Author: Emmanouil S. Saloustros